ASHY DERMATOSIS ASSOCIATED WITH ORAL ANTIDEPRESSANTS

  • Fred Bernardes Filho Pós Graduando de Dermatologia / Graduated in Dermatology, no Instituto de Dermatologia Professor Rubem David Azulay da Santa Casa da Misericórdia do Rio de Janeiro (IDPRDA - SCMRJ) - Rio de Janeiro (RJ), Brazil
  • Maria Victória Pinto Quaresma Santos Pós Graduanda de Dermatologia / Graduated in Dermatology, no Instituto de Dermatologia Professor Rubem David Azulay da Santa Casa da Misericórdia do Rio de Janeiro (IDPRDA - SCMRJ) - Rio de Janeiro (RJ), Brazil
  • Felipe Nazareth de Matos Pinto de Carvalho Pós Graduando de Dermatologia / Graduated in Dermatology, na Universidade Federal do Rio de Janeiro (UFRJ) - Rio de Janeiro (RJ), Brazil
  • Paulo Henrique Cordeiro de Oliveira Acadêmicos deMedicina /Medical Academic, da Universidade do Grande Rio (UNIGRANRIO), Rio de Janeiro (RJ), Brazil
  • Marco Antônio Bianco de Soto Acadêmicos de Medicina /Medical Academic, da Universidade do Grande Rio (UNIGRANRIO), Rio de Janeiro (RJ), Brazil
  • Fernanda da Fonseca Oliveira Acadêmicos deMedicina /Medical Academic, da Universidade do Grande Rio (UNIGRANRIO), Rio de Janeiro (RJ), Brazil
  • Franciely Silva Acadêmicos deMedicina /Medical Academic, da Universidade do Grande Rio (UNIGRANRIO), Rio de Janeiro (RJ), Brazil
  • Carlos Gustavo Carneiro de Castro Dermatologista Especialista / Specialist of Dermatology, pela Sociedade Brasileira de Dermatologia (SBD) e Associação Médica Brasileira (AMB)

Abstract

Ashy dermatosis or erythema dyschromicum perstans (EDP) is a clinical syndrome with a controversial classification. The condition is rare in Brazil. It was initially reported in El Salvador but has also been found in several South American countries and in other regions of the world. Its etiology is unknown; however, some authors believe that it represents a diffuse presentation of fixed drug eruption, while others consider it to be a variant of lichen planus pigmentosus in view of the similar histopathological findings. Clinically, the condition presents with lesions in the form of numerous gray macules of varying sizes. There is no effective treatment to date; however, benefits have been repor- ted with the use of clofazimine. In this report, the authors describe a case of ashy dermatosis associated with the use of serotonin-specific reuptake inhibitors.

KEYWORDS – Skin diseases; Erythema; Hyperpigmentation; Drug eruptions; Lichen planus. 

Downloads

Download data is not yet available.
Published
2013-06-23
How to Cite
Filho, F. B., Santos, M. V. P. Q., de Carvalho, F. N. de M. P., de Oliveira, P. H. C., de Soto, M. A. B., Oliveira, F. da F., Silva, F., & de Castro, C. G. C. (2013). ASHY DERMATOSIS ASSOCIATED WITH ORAL ANTIDEPRESSANTS. Journal of the Portuguese Society of Dermatology and Venereology, 71(1), 85-88. https://doi.org/10.29021/spdv.71.1.128
Section
Case Reports

Most read articles by the same author(s)